PaxMedica, Inc. (PXMD)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Feb 21, 2025, 10:56 AM EST

PaxMedica Statistics

Total Valuation

PaxMedica has a market cap or net worth of 1,131. The enterprise value is -323,349.

Market Cap 1,131
Enterprise Value -323,349

Important Dates

The next estimated earnings date is Wednesday, March 12, 2025.

Earnings Date Mar 12, 2025
Ex-Dividend Date n/a

Share Statistics

PaxMedica has 11.31 million shares outstanding. The number of shares has increased by 606.41% in one year.

Current Share Class n/a
Shares Outstanding 11.31M
Shares Change (YoY) +606.41%
Shares Change (QoQ) +3.20%
Owned by Insiders (%) 0.72%
Owned by Institutions (%) 8.07%
Float 10.77M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 0.02
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.38

Current Ratio 0.38
Quick Ratio 0.15
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -11,794.75

Financial Efficiency

Return on equity (ROE) is -7,716.49% and return on invested capital (ROIC) is -909.14%.

Return on Equity (ROE) -7,716.49%
Return on Assets (ROA) -324.69%
Return on Invested Capital (ROIC) -909.14%
Return on Capital Employed (ROCE) 1,180.72%
Revenue Per Employee n/a
Profits Per Employee -2.52M
Employee Count 7
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -99.98% in the last 52 weeks. The beta is -0.57, so PaxMedica's price volatility has been lower than the market average.

Beta (5Y) -0.57
52-Week Price Change -99.98%
50-Day Moving Average 0.04
200-Day Moving Average 0.15
Relative Strength Index (RSI) 25.34
Average Volume (20 Days) 3,334

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.02

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -15.44M
Pretax Income -17.66M
Net Income -17.66M
EBITDA n/a
EBIT -15.44M
Earnings Per Share (EPS) -3.51
Full Income Statement

Balance Sheet

Cash & Cash Equivalents 324,486
Total Debt n/a
Net Cash 324,486
Net Cash Per Share 0.03
Equity (Book Value) -1.81M
Book Value Per Share -0.23
Working Capital -1.31M
Full Balance Sheet

Cash Flow

Operating Cash Flow -9.32M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

PaxMedica does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -606.41%
Shareholder Yield -606.41%
Earnings Yield -1,561,507.96%
FCF Yield n/a

Stock Splits

The last stock split was on October 31, 2023. It was a reverse split with a ratio of 0.0588235.

Last Split Date Oct 31, 2023
Split Type Reverse
Split Ratio 0.0588235

Scores

Altman Z-Score n/a
Piotroski F-Score n/a